DACLIZUMAB
N0000148541
http://purl.bioontology.org/ontology/NDFRT/N0000148541
D [Preparations]
Ingredient
DRUG_KIND
Decreased Cytokine Activity [PE]
Interleukin 2 Receptor Antagonists [MoA]
Decreased Lymphocyte Cell Production [PE]
DACLIZUMAB 5MG/ML INJ [VA Product]
daclizumab [Chemical/Ingredient]
Drug Hypersensitivity [Disease/Finding]
Graft vs Host Disease [Disease/Finding]
DACLIZUMAB/NATALIZUMAB [VA Drug Interaction]
Amino Acid, Peptide, or Protein
Pharmacologic Substance
Active
T116
T121
C0663182
50.416^3751^
50.6^3471^
4021083